Sort by
Refine Your Search
-
manufacturing procedures and the requirement for lymphodepleting chemotherapy, which together limit patient access. Here, we propose an in vivo engineering strategy based on targeted lipid nanoparticles (tLNPs
Enter an email to receive alerts for nanoparticle-"https:" positions